Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
215.44
+4.06 (1.92%)
At close: Aug 26, 2026, 4:00 PM EDT
218.00
+2.56 (1.19%)
After-hours: Aug 26, 2026, 7:59 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $46.18 billion as of August 26, 2026. Its market cap has increased by 592.52% in one year.
Market Cap
46.18B
Enterprise Value
43.43B
1-Year Change
592.52%
Ranking
Category
Stock Price
$215.44
ChartMarket Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $46.18B, an increase of 2,707.98%. That is a compound annual growth rate of 66.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 46.18B | 199.89% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 82.40B |
| argenx SE | 65.85B |
| Moderna | 53.06B |
| BeOne Medicines AG | 41.54B |
| Royalty Pharma | 35.12B |
| Alnylam Pharmaceuticals | 30.89B |
| BioNTech SE | 27.99B |
| Insmed | 27.23B |